'Normal' urothelium in patients with bladder cancer. A preliminary report from the National Bladder Cancer Collaborative Group A

W. M. Murphy, G. K. Nagy, M. K. Rao, M. S. Soloway, G. C. Parija, C. E. Cox IInd, G. H. Friedell

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The concept that most bladder carcinomas arise from a widespread reaction of urothelial cells to various carcinogenic stimuli is widely accepted. The evidence for this theory rests largely on retrospective evaluations of nontumorous urothelium obtained from patients with concomitant or sinecomitant bladder cancers. A prospective surveillance study of patients with bladder cancer has been conducted at the University of Tennessee Center for the Health Sciences, a collaborating institution of the National Bladder Cancer Collaborative Group-A, to determine the frequency, distribution, and biologic significance of hyperplasia, dysplasia, carcinoma in situ (CIS), and carcinoma in the cystoscopically unremarkable urothelium of patients with carcinoma of the bladder. Multiple mucosal biopsies were obtained at cystoscopy from preselected sites in 64 patients. Specimens were collected both when tumors were visible and when no tumor was seen. Of the 657 evaluable specimens, 94 (14.3%) were positive for either hyperplasia, dysplasia, carcinoma in situ, or carcinoma (invasive and/or papillary, noninvasive). In general, the frequency of positive biopsies increased with advancing histologic grade of the primary neoplasm. When possible, incomplete resection of the primary tumor was taken into consideration; there was no statistically significant difference between frequency of positive specimens collected from sites adjacent to versus distant from the original neoplasm. Patients were no more likely to have abnormal urothelium when a tumor was cystoscopically visible than when no tumor was apparent, but lesions occurring in the presence of a tumor tended to be of greater histologic severity. The biologic significance of flat, noninvasive urothelial lesions (hyperplasia, dysplasia, CIS) can be determined only after longer periods of observations, but preliminary results indicate a borderline statistical significance (p congruent to .10) for these abnormalities in the prediction of subsequent recurrence or new occurrence of bladder cancer.

Original languageEnglish
Pages (from-to)1050-1058
Number of pages9
JournalCancer
Volume44
Issue number3
DOIs
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Urothelium
Urinary Bladder Neoplasms
Neoplasms
Carcinoma in Situ
Hyperplasia
Carcinoma
Urinary Bladder
Biopsy
Cystoscopy
Prospective Studies
Recurrence
Health

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

'Normal' urothelium in patients with bladder cancer. A preliminary report from the National Bladder Cancer Collaborative Group A. / Murphy, W. M.; Nagy, G. K.; Rao, M. K.; Soloway, M. S.; Parija, G. C.; Cox IInd, C. E.; Friedell, G. H.

In: Cancer, Vol. 44, No. 3, 01.12.1979, p. 1050-1058.

Research output: Contribution to journalArticle

Murphy, W. M. ; Nagy, G. K. ; Rao, M. K. ; Soloway, M. S. ; Parija, G. C. ; Cox IInd, C. E. ; Friedell, G. H. / 'Normal' urothelium in patients with bladder cancer. A preliminary report from the National Bladder Cancer Collaborative Group A. In: Cancer. 1979 ; Vol. 44, No. 3. pp. 1050-1058.
@article{095ca23da25140ecb894ed9b500a0dcb,
title = "'Normal' urothelium in patients with bladder cancer. A preliminary report from the National Bladder Cancer Collaborative Group A",
abstract = "The concept that most bladder carcinomas arise from a widespread reaction of urothelial cells to various carcinogenic stimuli is widely accepted. The evidence for this theory rests largely on retrospective evaluations of nontumorous urothelium obtained from patients with concomitant or sinecomitant bladder cancers. A prospective surveillance study of patients with bladder cancer has been conducted at the University of Tennessee Center for the Health Sciences, a collaborating institution of the National Bladder Cancer Collaborative Group-A, to determine the frequency, distribution, and biologic significance of hyperplasia, dysplasia, carcinoma in situ (CIS), and carcinoma in the cystoscopically unremarkable urothelium of patients with carcinoma of the bladder. Multiple mucosal biopsies were obtained at cystoscopy from preselected sites in 64 patients. Specimens were collected both when tumors were visible and when no tumor was seen. Of the 657 evaluable specimens, 94 (14.3{\%}) were positive for either hyperplasia, dysplasia, carcinoma in situ, or carcinoma (invasive and/or papillary, noninvasive). In general, the frequency of positive biopsies increased with advancing histologic grade of the primary neoplasm. When possible, incomplete resection of the primary tumor was taken into consideration; there was no statistically significant difference between frequency of positive specimens collected from sites adjacent to versus distant from the original neoplasm. Patients were no more likely to have abnormal urothelium when a tumor was cystoscopically visible than when no tumor was apparent, but lesions occurring in the presence of a tumor tended to be of greater histologic severity. The biologic significance of flat, noninvasive urothelial lesions (hyperplasia, dysplasia, CIS) can be determined only after longer periods of observations, but preliminary results indicate a borderline statistical significance (p congruent to .10) for these abnormalities in the prediction of subsequent recurrence or new occurrence of bladder cancer.",
author = "Murphy, {W. M.} and Nagy, {G. K.} and Rao, {M. K.} and Soloway, {M. S.} and Parija, {G. C.} and {Cox IInd}, {C. E.} and Friedell, {G. H.}",
year = "1979",
month = "12",
day = "1",
doi = "10.1002/1097-0142(197909)44:3<1050::AID-CNCR2820440337>3.0.CO;2-N",
language = "English",
volume = "44",
pages = "1050--1058",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - 'Normal' urothelium in patients with bladder cancer. A preliminary report from the National Bladder Cancer Collaborative Group A

AU - Murphy, W. M.

AU - Nagy, G. K.

AU - Rao, M. K.

AU - Soloway, M. S.

AU - Parija, G. C.

AU - Cox IInd, C. E.

AU - Friedell, G. H.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - The concept that most bladder carcinomas arise from a widespread reaction of urothelial cells to various carcinogenic stimuli is widely accepted. The evidence for this theory rests largely on retrospective evaluations of nontumorous urothelium obtained from patients with concomitant or sinecomitant bladder cancers. A prospective surveillance study of patients with bladder cancer has been conducted at the University of Tennessee Center for the Health Sciences, a collaborating institution of the National Bladder Cancer Collaborative Group-A, to determine the frequency, distribution, and biologic significance of hyperplasia, dysplasia, carcinoma in situ (CIS), and carcinoma in the cystoscopically unremarkable urothelium of patients with carcinoma of the bladder. Multiple mucosal biopsies were obtained at cystoscopy from preselected sites in 64 patients. Specimens were collected both when tumors were visible and when no tumor was seen. Of the 657 evaluable specimens, 94 (14.3%) were positive for either hyperplasia, dysplasia, carcinoma in situ, or carcinoma (invasive and/or papillary, noninvasive). In general, the frequency of positive biopsies increased with advancing histologic grade of the primary neoplasm. When possible, incomplete resection of the primary tumor was taken into consideration; there was no statistically significant difference between frequency of positive specimens collected from sites adjacent to versus distant from the original neoplasm. Patients were no more likely to have abnormal urothelium when a tumor was cystoscopically visible than when no tumor was apparent, but lesions occurring in the presence of a tumor tended to be of greater histologic severity. The biologic significance of flat, noninvasive urothelial lesions (hyperplasia, dysplasia, CIS) can be determined only after longer periods of observations, but preliminary results indicate a borderline statistical significance (p congruent to .10) for these abnormalities in the prediction of subsequent recurrence or new occurrence of bladder cancer.

AB - The concept that most bladder carcinomas arise from a widespread reaction of urothelial cells to various carcinogenic stimuli is widely accepted. The evidence for this theory rests largely on retrospective evaluations of nontumorous urothelium obtained from patients with concomitant or sinecomitant bladder cancers. A prospective surveillance study of patients with bladder cancer has been conducted at the University of Tennessee Center for the Health Sciences, a collaborating institution of the National Bladder Cancer Collaborative Group-A, to determine the frequency, distribution, and biologic significance of hyperplasia, dysplasia, carcinoma in situ (CIS), and carcinoma in the cystoscopically unremarkable urothelium of patients with carcinoma of the bladder. Multiple mucosal biopsies were obtained at cystoscopy from preselected sites in 64 patients. Specimens were collected both when tumors were visible and when no tumor was seen. Of the 657 evaluable specimens, 94 (14.3%) were positive for either hyperplasia, dysplasia, carcinoma in situ, or carcinoma (invasive and/or papillary, noninvasive). In general, the frequency of positive biopsies increased with advancing histologic grade of the primary neoplasm. When possible, incomplete resection of the primary tumor was taken into consideration; there was no statistically significant difference between frequency of positive specimens collected from sites adjacent to versus distant from the original neoplasm. Patients were no more likely to have abnormal urothelium when a tumor was cystoscopically visible than when no tumor was apparent, but lesions occurring in the presence of a tumor tended to be of greater histologic severity. The biologic significance of flat, noninvasive urothelial lesions (hyperplasia, dysplasia, CIS) can be determined only after longer periods of observations, but preliminary results indicate a borderline statistical significance (p congruent to .10) for these abnormalities in the prediction of subsequent recurrence or new occurrence of bladder cancer.

UR - http://www.scopus.com/inward/record.url?scp=0018694931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018694931&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197909)44:3<1050::AID-CNCR2820440337>3.0.CO;2-N

DO - 10.1002/1097-0142(197909)44:3<1050::AID-CNCR2820440337>3.0.CO;2-N

M3 - Article

C2 - 476586

AN - SCOPUS:0018694931

VL - 44

SP - 1050

EP - 1058

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -